Atantares

Suzhou, China · Founded 2017 · Privately Held (backing)

Developer of precision medicines and smart diagnostic devices designed to transform disease management across hematology, cardiology, neurology and cancer. Atantares is based in Suzhou, China and was founded in 2017. Its last reported valuation was $14.5 million in Jul 2025. It has raised $28 million.

Last reported valuation
$14.5M
Oct 2026
Priced at
—
Total raised
$28.0M
Last round
—

Who backs Atantares?

17 investors
InvestorType
US National Science FoundationOther
Qiming Venture PartnersVenture capital
Aramco VenturesOther
Frees FundOther
Leader Venture CapitalOther
Huatai Zijin InvestmentOther
MIT.nanoOther
Suzhou Angel Fund of FundsOther
Alibaba Health Information Technology—
Asia Green Fund—
+ 7 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Atantares investors

17 investors are on record for Atantares, including US National Science Foundation, Qiming Venture Partners, Aramco Ventures and Frees Fund.

Free account
More of Atantares with a free account
  • ·The complete investor list: 17 names
  • ·Watch Atantares: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 17 firms already write checks for companies like Atantares. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View